The proportion of AKR1C1-positive patients tended toward larger tumor size (≥3 cm) (P = 0.003) and higher risk of lymph node metastasis (P = 0.03) (Table 1 and Fig. 2D, E). Here, AKR1C1 is linked to metastatic malignant neoplasm in the lymph nodes.